Regardless of how much weight you lose, GLP-1 drugs like Wegovy and Ozempic could decrease major adverse cardiovascular events.
Phase 3 study presentations in SLE to show efficacy results across multiple clinical endpoints, including low disease ...
A research team has unveiled a sustainable and highly efficient method to produce the FDA-approved acne drug clascoterone.
Telitacicept, a new dual inhibitor of the cytokines B-lymphocyte stimulator (BLyS) and APRIL (a proliferation-inducing ligand ...
A popular hair-loss drug may have dangerous mental health effects long dismissed by authorities. Scientists now demand urgent ...
The number of people receiving treatment for cancer has risen dramatically in the last decade in many African countries. For ...
NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), announced that its clinical lead drug NV ...
Elevated calcium levels in the blood—a complication of kidney cancers known as hypercalcemia—may be successfully treated with ...
Data from this study, together with results from the Phase 1a/1b ulcerative colitis (UC) program, are expected to support Phase 2 Investigational New Drug (IND) submissions to the U.S. Food and Drug ...
A new review by a public health expert from the Hebrew University of Jerusalem reveals that finasteride, a common hair-loss drug, has been linked to depression and suicide for over two decades — yet ...
Finasteride has long been a popular choice for millions of people seeking to achieve thicker hair. It was marketed as a ...
The Food & Drug Administration granted AbbVie expanded approval for its Rinvoq drug intended to treat moderately to severely active ulcerative colitis and moderately to severely active Crohn's disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results